XM does not provide services to residents of the United States of America.
F
F

FreseniusMedical


News

Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement With Premier, Inc.

BRIEF-Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement With Premier, Inc. Nov 19 (Reuters) - FRESENIUS MEDICAL CARE AG FMEG.DE : FRESENIUS MEDICAL CARE AWARDED MECHANICAL CIRCULATORY SUPPORT AGREEMENT WITH PREMIER, INC. FOR THE NOVALUNG® ECMO SYSTEM Source text: ID:nPnbNNcK4a Further company coverage: FMEG.DE (Gdansk Newsroo
F

Fresenius soars on Q3 beat across the board

BUZZ-Fresenius soars on Q3 beat across the board ** German healthcare company Fresenius FREG.DE rises 6.6% after the company reported better-than-expected third-quarter results . ** The company reported a 7% increase in group revenues to 5.3 billion euros and a 8% increase in adjusted EBIT, which came in at 552 million euros. ** The results were "ahead of consensus expectations across the board", Berenberg said ** "The better-than-expected performance was driven by core operating performance and
F
F
G

Elisa, Nexus, Telia

EUROPE RESEARCH ROUNDUP-Elisa, Nexus, Telia Nov 6 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Elisa, Nexus and Telia on Wednesday. HIGHLIGHTS * Elisa Oyj ELISA.HE : Barclays raises to overweight from underweight * Inficon Holding AG IFCN.S : Berenberg raises to buy from hold * Nexus AG NXUG.DE : Stifel cuts to hold from buy * Telenor ASA TEL.OL : Barclays cuts to equal weight from overweight * Telia TELIA.ST : Barclays cuts to u
3
A
A
A
B
B
B
B
C
D
D
E
E
H
H
H
T
T
T
A
B
F
R
S

Germany's Fresenius raises 2024 forecast after Q3 beat

UPDATE 2-Germany's Fresenius raises 2024 forecast after Q3 beat, shares rise Adds share move in paragraph 4, analyst comment in paragraph 6, FMC result in paragraph 7, net debt in paragraph 8, savings objective in paragraph 11 By Tristan Veyet and Rafal Wojciech Nowak Nov 6 (Reuters) - Germany's Fresenius FREG.DE raised its full-year outlook on Wednesday after beating third-quarter expectations, citing strong performances at its Kabi and Helios divisions and deleveraging efforts paying off , sen
F
F

Fresenius Medical Care AG reports results for the quarter ended in September 30 - Earnings Summary

Fresenius Medical Care AG reports results for the quarter ended in September 30 - Earnings Summary Fresenius Medical Care AG FMEG.DE reported quarterly adjusted earnings of 82 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 57 cents. The mean expectation of seven analysts for the quarter was for earnings of 65 cents per share.
F

FMC specifies 2024 guidance as it tops Q3 core profit forecast

UPDATE 2-FMC slightly raises 2024 guidance as it tops Q3 core profit forecast Adds CEO quotes in paragraphs 3, 9, shares in paragraph 6, peer performance in paragraph 7 By Bartosz Dabrowski and Patricia Weiss Nov 5 (Reuters) - Dialysis specialist Fresenius Medical Care FMEG.DE slightly raised the lower end of its 2024 operating profit forecast range on Tuesady after posting quarterly earnings above expectations, helped by cost savings and as its U.S.
F
D

FMC Q3 Operating Income Up 43% At EUR 463 Mln

BRIEF-FMC Q3 Operating Income Up 43% At EUR 463 Mln Nov 5 (Reuters) - FRESENIUS MEDICAL CARE AG FMEG.DE : FY 2024 OPERATING INCOME GROWTH OUTLOOK OF 16-18% EXCEEDING FULL YEAR FME25 SAVINGS TARGET, WITH ADDITIONAL EUR 64 MILLION CONTRIBUTION IN Q3 Q3 OPERATING INCOME INCREASED BY 43% TO EUR 463 MILLION VERSUS CONSENSUS EUR 434 MILLION Q3 BASIC EARN
F

Dialysis specialist FMC tops quarterly core profit forecast

Dialysis specialist FMC tops quarterly core profit forecast Nov 5 (Reuters) - World's largest dialysis specialist Fresenius Medical Care FMEG.DE reported third-quarter operating profit above market expectations on Tuesday, helped by additional savings from its FME25 transformation programme. The German company said its adjusted operating income grew 42.7% to 463 million euros ($504 million) in the July-September period, versus analysts' median estimate of 434 million euros in a company-provided
F

Fresenius Medical Care AG <FMS.N> expected to post earnings of 35 cents a share - Earnings Preview

Fresenius Medical Care AG expected to post earnings of 35 cents a share - Earnings Preview Fresenius Medical Care AG FMS.N , FMS is expected to show a fall in quarterly revenue when it reports results on November 5 for the period ending September 30 2024 The Bad Homburg Vor Der Hohe Hessen-based company is expected to report a 0.9% decrease in revenue to €4.891 billion from €4.94 billion a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
F

Adecco, Bodycote, LVMH

EUROPE RESEARCH ROUNDUP-Adecco, Bodycote, LVMH Oct 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adecco, Bodycote and LVMH, on Wednesday. HIGHLIGHTS * Adecco ADEN.S : Deutsche Bank raises to buy from hold * Bodycote Plc BOY.L : JP Morgan cuts target price to 670p from 750p * DNB Bank ASA DNB.OL : JP Morgan raises target price to NOK 230 from NOK 220 * Fabege AB FABG.ST : Kepler Cheuvreux raises to buy from hold * LVMH LVMH.PA
A
B
B
B
B
B
C
C
E
F
F
G
H
H
I
I
L
L
P
A
F

Baxter bringing back hurricane-hit IV supply facility in stages

UPDATE 4-Baxter bringing back hurricane-hit IV supply facility in stages Adds B.Braun statement in paragraph 8 By Christy Santhosh and Kashish Tandon Oct 9 (Reuters) - Baxter International BAX.N is bringing its hurricane-hit IV manufacturing facility in North Carolina back online in stages, with a goal of restoring 90% to 100% of customer needs by the end of the year, the company said on Wednesday.
F
H

Fresenius looking to boost output after hurricane damage at rival Baxter

UPDATE 4-Fresenius looking to boost output after hurricane damage at rival Baxter Updates Oct 8 story to add additional Fresenius comment, paragraph 4 FRANKFURT, Oct 9 (Reuters) - Germany's Fresenius FREG.DE said it was checking options to speed up the start of new production lines of medical equipment at a North Carolina facility to help mitigate potential shortages from hurricane damage to rival Baxter's BAX.N site in the same state.
F
F

Top of the Street: Roche, Fresenius, BASF, AstraZeneca, Rational, PSP Swiss Property, Swiss Prime Site

BUZZ-Top of the Street: Roche, Fresenius, BASF, AstraZeneca, Rational, PSP Swiss Property, Swiss Prime Site A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Deutsche Bank cuts Roche ROG.S to "sell" from "buy", citing limited catalyst due to a risk of Roche creating a lot of sunk cost for little ultimate return ** J.P.Morgan upgrades Fresenius FREG.DE to "overweight" from "neutral" as it sees earnings compression at the German healthcare group coming to an
A
B
F
J
R
R
S
P
F

'Medicine is starting to work', JPM upgrades Fresenius

BUZZ-'Medicine is starting to work', JPM upgrades Fresenius ** J.P.Morgan upgrades Fresenius FREG.DE to "overweight" from "neutral" as it sees earnings compression at the German healthcare group coming to an end ** The broker says Fresenius delivered results above expectations in each of the last four quarters and management made progress in improv
F
F

Banco, Shell, WH Smith

EUROPE RESEARCH ROUNDUP-Banco, Shell, WH Smith Sept 12 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Banco, Shell and WH Smith on Thursday. HIGHLIGHTS * ABN Amro Bank NV ABNd.AS : JP Morgan raises to neutral from underweight * Banco Bpm BAMI.MI : JP Morgan raises to neutral from underweight * Shell Plc SHEL.L : Berenberg cuts target price to 3,100p from 3,400p * UMG UMG.AS : Citigroup cuts target price to EUR 26 from EUR 29.50 *
A
B
B
B
C
C
C
C
D
D
D
D
E
E
E
E
I
I
I
N
O
P
R
R
R
S
S
W
P
A
B
B
F
L
U

Nestle replaces CEO Schneider with company veteran Freixe

UPDATE 6-Nestle replaces CEO Schneider with company veteran Freixe Adds Freixe's age and background in paragraph 15, and further comment, no other changes By John Revill and Richa Naidu ZURICH/LONDON, Aug 22 (Reuters) - Nestle NESN.S is replacing CEO Mark Schneider with company veteran Laurent Freixe, the Swiss food group said on Thursday, marking a change of leadership as it faces a challenge to grow sales.
D
N
F



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.